Similar articles

• Hyperlipidemia in stable renal transplant recipients.

  Ong-Ajyooth L, Sirisalee K, Shayakul C, Vareesangthip K, Vasuvattakul S, Chirawong P, Vanichakarn S, Nimmannit S, Ong-Ajyooth S, Nilwarangkur S. Ong-Ajyooth L, et al. Transplant Proc. 1994 Aug;26(4):2062-4. Transplant Proc. 1994. PMID: 8066670 No abstract available.
• Lipid metabolism and oxidative stress in renal transplantation: implications for chronic rejection.

  Cristol JP, Maggi MF, Vela C, Descomps B, Mourad G. Cristol JP, et al. Transplant Proc. 1996 Oct;28(5):2820-1. Transplant Proc. 1996. PMID: 8908078 No abstract available.
• Potential atherogenic roles of lipids, lipoprotein(a) and lipid peroxidation in preeclampsia.

  Bayhan G, Koçyigit Y, Atamer A, Atamer Y, Akkus Z. Bayhan G, et al. Gynecol Endocrinol. 2005 Jul;21(1):1-6. doi: 10.1080/09513590500097382. Gynecol Endocrinol. 2005. PMID: 16048794
• Apolipoproteins as markers and managers of coronary risk.

  Chan DC, Watts GF. Chan DC, et al. QJM. 2006 May;99(5):277-87. doi: 10.1093/qjmed/hcl027. Epub 2006 Feb 27. QJM. 2006. PMID: 16504986 Review.
• Role of lipids in chronic renal allograft rejection.

  Swan SK. Swan SK. Contrib Nephrol. 1997;120:62-7. doi: 10.1159/000059824. Contrib Nephrol. 1997. PMID: 9257048 Review. No abstract available.